Featured

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel. Over their development history, the therapeutic performance and value of DEDs has evolved significantly, and recent innovation has...

Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not extend far beyond the traditional exchange of funding and research. There is a risk, however,...

Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world. With the global market expected to...

Increasingly elaborate international clinical trials are demanding a smarter, streamlined approach from supply partners and better collaboration with sponsors. In this environment, Interactive Response Technology (IRT) systems have been a staple and a powerful, practical tool for optimizing a product’s...

As the global logistics and supply chain industry continues to grow — it is expected to reach $15.5 trillion by 2023 — pharmaceutical companies are facing more hurdles than ever to monitor their cargo as it passes through the...

Biotechnologically manufactured drugs are one of the most important pharmaceutical trends of the past years. Especially in cancer therapy, the advent of antibody-drug conjugates (ADCs) has opened the door for new, extremely promising treatment options. But these medications are also...

Coating technologies reduce particulate generation by up to 96% in pharmaceutical manufacturing. As the demand for prefilled and prefillable syringe applications grow, one consideration for many pharmaceutical manufacturers is particulate; in particular, how particulate can be reduced in the manufacturing...